About us
Mission statement
Supports and grants
Review cycle
Building Trust, Managing Risk: Vaccine Confidence and Human Papillomavirus Vaccination - June 2017
Prevention and control of HPV and HPV related cancers in Denmark: lessons learnt and the way forward - November 2016
Barriers in HPV vaccination & cervical screening programmes - June 2016
Kick off meeting - December 2015
HPV Board Newsletter
Journals and newsletters
Reports and documentaries
Guidelines from international organisations
Websites with HPV information
Vaccine safety
Vaccine Safety Net
Vaccine Safety Basics e-learning course


HPV Prevention and Control Board
Executive Secretariat
University of Antwerp
Campus Drie Eiken, R 2.18
Universiteitsplein 1
2160 Wilrijk
Tel. +32 (0)3 265 26 64

Why a HPV Prevention and Control Board?

With the achievements of decades of work on epidemiology, vaccines and test development, clinical trials, and new screening tools coming into public health and clinical use, the past years have been an exciting time for the Human Papilloma Virus (HPV) prevention community. 

Because of the availability of techniques that facilitate access to prevention, screening and treatment, we believe there is great value added in the establishment of an independent international multidisciplinary HPV prevention and control Board of top experts in the field. Experts who provide evidence based reflection and guidance on strategic, technical, and policy issues that will occur as we move forward in the implementation of our control programs. 

The HPV Board will assist in the monitoring and evaluation of national and regional control programs in support of international organizations such as World Health Organization (WHO), Centre for Disease control (CDC), and Gavi, The Vaccine Alliance.

Last update

Last update: 30/06/2017